MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

(2014) H-M Lin et al.   BRITISH JOURNAL OF CANCER

Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients

(2014) Donghai Men et al.   Cancer Epidemiology

Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer

(2013) Yuji Toiyama et al.   ANNALS OF SURGERY

Laparoscopic pelvic lymph node dissection system based on preoperative primary tumour stage (T stage) by computed tomography in urothelial bladder cancer: results of a single-institution prospective study

(2013) Jun-Bin Yuan et al.   BJU INTERNATIONAL

miR-146b-5p inhibits glioma migration and invasion by targeting MMP16

(2013) Yanyan Li et al.   CANCER LETTERS

EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines

(2013) J. Alfred Witjes et al.   EUROPEAN UROLOGY

Loss of microRNA-200a expression correlates with tumor progression in breast cancer

(2013) Kiseok Jang et al.   Translational Research

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer

(2012) S Miah et al.   BRITISH JOURNAL OF CANCER

Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer

(2012) Sheng Wang et al.   Diagnostic Pathology

MiR-155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs)viatargeting of MMP-16

(2012) Jia Liu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer

(2012) Manuel Valladares-Ayerbes et al.   Journal of Translational Medicine

pROC: an open-source package for R and S+ to analyze and compare ROC curves

(2011) Xavier Robin et al.   BMC BIOINFORMATICS

Does the Extent of Lymphadenectomy in Radical Cystectomy for Bladder Cancer Influence Disease-Free Survival? A Prospective Single-Center Study

(2011) Hassan Abol-Enein et al.   EUROPEAN UROLOGY

MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review

(2011) James W.F. Catto et al.   EUROPEAN UROLOGY

Clinical Nodal Staging Scores for Bladder Cancer: A Proposal for Preoperative Risk Assessment

(2011) Shahrokh F. Shariat et al.   EUROPEAN UROLOGY

Novel ZEB1 expression in bladder tumorigenesis

(2010) Patrick A. Kenney et al.   BJU INTERNATIONAL

Laparoscopic extended pelvic lymph node dissection during radical cystectomy: technique and clinical outcomes

(2010) Pengfei Shao et al.   BJU INTERNATIONAL

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer

(2010) Erik D. Wiklund et al.   INTERNATIONAL JOURNAL OF CANCER

Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

(2009) L. Dyrskjot et al.   CANCER RESEARCH

The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer

(2009) Arnulf Stenzl et al.   EUROPEAN UROLOGY

The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2

(2008) Manav Korpal et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

(2008) Philip A. Gregory et al.   NATURE CELL BIOLOGY